糖尿病视网膜病变 (DR)的临床试验
总计20160个结果
-
AEYE Health IncA. Stein Regulatory Affairs Consulting Ltd.招聘中
-
AbbVieAbbVie招聘中
-
LivaNova完全的在广泛的起搏器患者中评估 Symphony 2550 或 REPLYTM DR 的 AAISafeR/SafeR 算法的益处。意大利, 法国, 西班牙, 美国, 德国, 英国
-
Bristlecone Health, Inc.University of Minnesota未知
-
Assiut University尚未招聘OctA .FFA Findings in DR
-
Retina Institute of Hawaii未知糖尿病性黄斑水肿 | 增生性糖尿病视网膜病变 | 严重的非增殖性糖尿病视网膜病变 | 轻度非增殖性糖尿病视网膜病变 | 中度非增殖性糖尿病视网膜病变美国
-
Asociación para Evitar la Ceguera en México完全的增生性糖尿病视网膜病变 | Severe Nonproliferative | Active Photocoagulated Diabetic Retinopathy墨西哥
-
Asociación para Evitar la Ceguera en México未知
-
Ruijin HospitalShanghai Municipal Science and Technology Commission未知
-
Valo Health, Inc.招聘中
-
Odense University HospitalUniversity of Southern Denmark; Velux Fonden完全的
-
Association for Innovation and Biomedical Research...招聘中
-
Charles C Wykoff, PhD, MDRegeneron Pharmaceuticals完全的
-
Kyorin University完全的
-
University of Campania "Luigi Vanvitelli"Napoli CTO Hospital完全的增生性糖尿病视网膜病变
-
Retina Associates, Kansas CityGenentech, Inc.未知
-
JUNYAN ZHANGThe First People's Hospital of Xuzhou未知
-
Oregon Health and Science UniversityOregon Clinical and Translational Research Institute完全的
-
Ophthalmic Consultants of Long IslandRegeneron Pharmaceuticals完全的
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São Paulo; Fundação de Apoio ao Ensino Pesquisa e...未知增生性糖尿病视网膜病变
-
EyePoint Pharmaceuticals, Inc.完全的
-
Jaeb Center for Health ResearchNational Eye Institute (NEI); Genentech, Inc.完全的
-
Regeneron Pharmaceuticals完全的非增殖性糖尿病视网膜病变美国, 德国, 匈牙利, 日本, 波多黎各, 英国
-
JUNYAN ZHANGThe First People's Hospital of Xuzhou未知
-
PD Dr. med. Stephan MichelsNovartis; University Hospital, Zürich终止
-
Instituto do CoracaoCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.未知